{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:48Z","timestamp":1791919608427,"version":"4.3.4"},"reference-count":174,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":false},"short-container-title":["Cancer Drug Resist."],"abstract":"<jats:p>Antibody-Drug Conjugates (ADCs) have achieved significant success in cancer therapy by combining the targeting specificity of monoclonal antibodies with cytotoxic payloads. However, the concomitant issue of drug resistance has become increasingly prominent, with primary mechanisms including alterations in target antigen expression, impaired drug transport, and inhibition of cell death pathways. ADCs have also shown emerging therapeutic potential in the treatment of autoimmune diseases; for instance, ABBV-3373 has achieved initial success in this area, yet it also faces unique challenges such as the safety of long-term administration, immunogenicity, and heterogeneity of target cells. Addressing these challenges requires multidimensional innovations, including optimizing molecular design, exploring combination therapy strategies, and introducing artificial intelligence (AI)-assisted development. These efforts aim to transition ADCs from the traditional \u201ctargeted killing\u201d paradigm to intelligent and personalized precision delivery systems, thereby offering more therapeutic options for patients with cancer and autoimmune diseases.<\/jats:p>","DOI":"10.20517\/cdr.2025.49","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:14:27Z","timestamp":1751512467000},"update-policy":"https:\/\/doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":11,"title":["The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy"],"prefix":"10.20517","author":[{"given":"Meijiang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoquan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8410","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2394"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001084"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920962997"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00470-8"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4375120"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.06.001"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096282480240105071638"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.131"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2015.05.017"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1326281"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082212"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13945"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754436"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/jci180012"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363906"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8753"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00023-5"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0229-x"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2024.2344647"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.05.006"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00709-2"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_390094"},{"key":"B24","unstructured":"U.S. food and drug administration. FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-hr-positive-her2-negative-breast. [Last accessed on 24 Jun 2025]."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1378010"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122676"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-19-0582"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1880562"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.3c00374"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00947-7"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1021\/bc0600214"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020032"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204764"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101429"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28967"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz035"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.268"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0166"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.04.012"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1203073"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-09-3546"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscia.2024.100048"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/0141-8130(95)01074-2"},{"key":"B44","unstructured":"Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1156829"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400109"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2229101"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020447"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00339"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00961"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-023-00505-8"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1177\/2040620715596715"},{"key":"B53","unstructured":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010715)92:2<406::aid-cncr1336>3.0.co;2-u"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-466706"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31317"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1509277"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061845"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107803"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00139-x"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.002"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0519-6"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814213"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071491"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231183679"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122898"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12387"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225368"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.03.012"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.34.15_suppl.lba8505"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.07.026"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122910"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-0879-y"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15888"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01579"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00494"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02822-z"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.1039"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-021-01537-z"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028845"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/jci124466"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/jci127101"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052505"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.14740\/jh1035"},{"key":"B86","unstructured":"ClinicalTrials.gov. Brentuximab vedotin for systemic sclerosis (BRAVOS). Available from: https:\/\/clinicaltrials.gov\/study\/NCT03222492?cond=NCT03222492&rank=1&tab=results. [Last accessed on 24 Jun 2025]."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae235"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.103"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-2952(03)00122-9"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.175"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00337"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.8b00312"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.04.008"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1516419"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.5b00603.s001"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-018-0302-5"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102922"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2023.41.16_suppl.e15011"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkad069"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0064"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9790-0"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267091"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071807"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202249947"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030713"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/art.42415"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03452-0"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101086"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/jci172156"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119674"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-14-0862"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv577"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041278"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk134"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024023930"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s135571"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-17-0403"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-3127"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac063"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-012-9402-8"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1021\/jm500766w"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-17-0296"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13761"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.10.025"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0926"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.03.277"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093271"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2018-0259"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08813-6"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010611-134654"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/antib7020016"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m113.513366"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-541-5_5"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124757"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104475"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-78154-9"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-16-0658"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00624-9"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23793-7"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.10.043"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.589"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00159-1"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbz009"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1093666"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102395"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac4925"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.12.008"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01509-2"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-0696"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.24"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-18-0743"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1186-0"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw157"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1124039"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.54097\/84jqhm90"},{"key":"B156","unstructured":"OncLive. BiTEs, CAR T-cell therapy, and ADCs offer variety of lymphoma treatment options, but questions remain. Available from: https:\/\/www.onclive.com\/view\/bites-car-t-cell-therapy-and-adcs-offer-variety-of-lymphoma-treatment-options-but-questions-remain. [Last accessed on 24 Jun 2025]."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02024-9"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2022.100128"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5b00620"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.37349\/eaa.2024.00052"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.883"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.compchemeng.2024.108585"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245923"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07487-w"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041472"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-023-09884-6"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/jimaging8080213"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00530-5"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2022.06.008"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081414"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84630-x"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.5152\/dir.2019.19125"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1007\/s11747-019-00710-5"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-023-01634-5"}],"container-title":["Cancer Drug Resistance"],"original-title":[],"link":[{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2025.49","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2025.49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:14:30Z","timestamp":1751512470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2025.49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":174,"URL":"https:\/\/doi.org\/10.20517\/cdr.2025.49","relation":{},"ISSN":["2578-532X"],"issn-type":[{"value":"2578-532X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}